However, recent research has demonstrated that the loss of MAP2K3 copy number occurs in NSCLC and that MAP2K3 inhibits cell proliferation and promotes cellular senescence in hepatocellular carcinoma, breast cancer, and melanoma [7, 18, 19, 20, 21]. Here, MAP2K3 is linked to hepatocellular carcinoma.